Temporal expression of galectin-3 following myocardial infarction.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25643429)

Published in Acta Cardiol on December 01, 2014

Authors

Thomas D Milner, Alexandra C Viner, Alison C MacKinnon, Tariq Sethi, Andrew D Flapan

Articles by these authors

Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J (2009) 3.02

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol (2008) 2.83

Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A (2006) 2.75

Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ (2004) 2.47

Regulation of alternative macrophage activation by galectin-3. J Immunol (2008) 2.28

Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med (2011) 2.15

Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med (2011) 2.09

Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure. Gut (2006) 1.82

The regulation of inflammation by galectin-3. Immunol Rev (2009) 1.76

Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv (2010) 1.75

Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. Am Heart J (2004) 1.45

Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum. J Cell Sci (2010) 1.45

Vascular effects of apelin in vivo in man. J Am Coll Cardiol (2008) 1.33

Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol (2008) 1.28

Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem (2007) 1.23

Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol (2009) 1.22

CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem (2004) 1.22

CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res (2014) 1.12

Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl (2004) 1.07

Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell (2002) 1.04

Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial. Trials (2012) 1.01

Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol (2002) 1.01

Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) (2002) 1.01

The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration (2011) 0.98

Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis (2007) 0.95

Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol (2013) 0.92

Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol (2004) 0.91

Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration. PLoS One (2012) 0.90

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. Glycobiology (2013) 0.90

Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate. Int J Cancer (2012) 0.89

Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3. Transplantation (2012) 0.89

The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull (2010) 0.88

Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? QJM (2012) 0.87

Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study. Circ Cardiovasc Interv (2008) 0.85

Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007. Circ Cardiovasc Interv (2010) 0.84

Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology (2004) 0.84

Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl (2002) 0.83

Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in Scotland. J Public Health (Oxf) (2008) 0.83

Targeting growth factors in lung cancer. Chest (2008) 0.82

Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers. Heart (2012) 0.81

Polysialic acid/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury. Hepatology (2014) 0.81

Advances in Molecular Biology of Lung Disease: Aiming for Precision Therapy in Non-small Cell Lung Cancer. Chest (2015) 0.80

Microdroplet digital PCR: detection and quantitation of biomarkers in archived tissue and serial plasma samples in patients with lung cancer. J Thorac Oncol (2015) 0.79

Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. Br J Pharmacol (2009) 0.78

[D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Methods Mol Med (2003) 0.78

Abnormalities of the repolarization characteristics of patients with heart failure progress with symptom severity. Ann Noninvasive Electrocardiol (2004) 0.78

Phospholipase C epsilon suppresses integrin activation. J Biol Chem (2006) 0.77

Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial. BMJ Open (2013) 0.77

Infusion of Mg in humans acutely reduces serum insulin levels: a pilot study. Magnes Res (2011) 0.77

Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev Anticancer Ther (2002) 0.77

Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation. Clin Sci (Lond) (2005) 0.76

DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature. Thorax (2015) 0.75

Early morning changes in QT/RR relationship in patients with inducible VT. Pacing Clin Electrophysiol (2004) 0.75

Noxious arousal induces T-wave changes in healthy subjects. J Electrocardiol (2006) 0.75

Is myocardial ischemia really bad for you? Expert Rev Cardiovasc Ther (2014) 0.75